Recommended
Recommended
More Related Content
Similar to Strategic Management Assignment Presentation on Competitor Analysis in Pharmaceutical Industry
Similar to Strategic Management Assignment Presentation on Competitor Analysis in Pharmaceutical Industry (20)
Recently uploaded
Recently uploaded (20)
Strategic Management Assignment Presentation on Competitor Analysis in Pharmaceutical Industry
- 1. STRATEGIC MANAGEMENT GROUP PRESENTATION- MBA 2 E GROUP NO. 5 OUR MEMBERS- Vinita Kumari Visist Tiwari Vivek Gupta Walia Fatima Wasi Arshad Yash Gupta Yashi Kesarwani Yashi Saini Yogesh Chandra Joshi Saumya Agarwal
- 3. TABLE OF CONTENT: ABOUT PHARMACEUTICAL INDUSTRY 5 SELECTED COMPETITOR PRODUCTS & SERVICES OFFER BY THEM FINANCIAL RESOURCES OF COMPETITORS BUSINESS MODEL MARKET SHARES OF COMPETITORS MARKETING STRATEGY OF COMPETITORS STRENGTH OF COMPETITORS WEEKNESS OF COMPETITORS
- 4. ABOUT PHARMACEUTICAL INDUSTRY IN INDIA India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications. The Indian Pharmaceutical industry is currently ranked third in pharmaceutical production by volume after evolving over time into a thriving industry growing at a CAGR of 9.43% since the past nine years. Generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics are some of the major segments of the Indian pharma industry. India has the most number of pharmaceutical manufacturing facilities that are in compliance with the US Food and Drug Administration (USFDA) and has 500 API producers that make for around 8% of the worldwide API market. https://www.ibef.org/industry/pharmaceutical-india
- 5. 5 SELECTED COMPETITOR 1. SUN PHARMACETICAL LTD. 2. CIPLA LTD. 3. DR. REDDY’S LABORATORIES LTD. 4. TORRENT PHARMACEUTICALS LTD. 5.MANKIND PHARMA
- 6. COMPAN Y PRICERS. MCAPCR. P/B P/E EPSRS. ROE% ROCE% P/S EV/EBITDA Sun Pharma Inds. 1,259.45 3,02,184.24 12.57 411.03 3.06 7.00 7.28 14.52 50.64 Cipla 1,246.30 1,00,620.08 3.89 34.01 36.65 10.49 14.71 6.37 20.25 Dr. Reddy''s Lab 5,797.90 96,714.42 4.26 25.26 229.54 13.57 18.91 5.70 15.29 Mankind Pharma 1,982.50 79,416.66 9.16 63.62 31.16 17.43 21.20 9.77 42.64 Torrent Pharma 2,305.55 78,030.29 11.37 71.07 32.44 16.43 18.10 10.14 30.05 Peer Comparison https://www.topstockresearch.com/rt/Stock/ MANKIND/FundamentalAnalysis
- 7. FINANCIAL RESOURCES OF COMPETITORS Field TTM YoY Growth QoQ Growth Revenue 46304.89 (Cr) 13.53 % 2.11 % Gross Profit 35500.64 (Cr) 60.38 % 2.42 % EBITDA 12797.78 (Cr) 79.34 % 6.98 % Net Profit 8548.53 (Cr) 161.58 % 17.45 % EPS 35.63 159.56 % NA Growth Key Fields SUNPHARMA DRREDDY Field TTM YoY Growth QoQ Growt h Revenue 26765.50 (Cr) 14.50 % 2.14 % Gross Profit 18108.00 (Cr) 78.30 % 1.65 % EBITDA 8251.10 (Cr) 75.01 % 3.89 % Net Profit 5091.20 (Cr) 106.52 % 5.49 % EPS 305.86 106.33 % NA Growth Key Fields https://www.topstockresearch.com/
- 8. Field TTM YoY Growth QoQ Growth Revenue 24556.43 (Cr) 4.55 % 5.52 % Gross Profit 15805.98 (Cr) 8.33 % 8.25 % EBITDA 6157.86 (Cr) 14.37 % 15.70 % Net Profit 3453.22 (Cr) 10.78 % 13.58 % EPS 42.78 11.28 % NA CIPLA Field TTM YoY Growth QoQ Growth Revenue 10233.00 (Cr) 13.07 % 2.66 % Gross Profit 7343.00 (Cr) 10.95 % 3.69 % EBITDA 2953.00 (Cr) 34.72 % 17.82 % Net Profit 1334.00 (Cr) 60.19 % 2.12 % EPS 39.41 60.16 % NA TORNT PHARM Field TTM YoY Growth QoQ Growth Revenue 9430.32 (Cr) 12.44 % 5.02 % Gross Profit 1758.66 (Cr) 100.00 % 100.00 % EBITDA 2370.48 (Cr) 7.64 % 3.53 % Net Profit 1557.49 (Cr) 10.58 % 2.91 % EPS 38.87 10.56 % NA MANKIND
- 10. Rank Company Market Share (December 2023) 1 Sun Pharma ₹295,466 crore (US$37 billion) 2 Cipla ₹100,787 crore (US$13 billion) 3 Dr. Reddy's Laboratories ₹98,218 crore (US$12 billion) 4 Divi's Laboratories ₹96,242 crore (US$12 billion) 5 Mankind Pharma ₹76,792 crore (US$9.6 billion) 6 Torrent Pharmaceuticals ₹72,168 crore (US$9.0 billion) 7 Zydus Lifesciences ₹64,305 crore (US$8.1 billion) 8 Aurobindo Pharma ₹61,154 crore (US$7.7 billion) 9 Lupin ₹57,530 crore (US$7.2 billion) 10 Alkem Laboratories ₹55,064 crore (US$6.9 billion MARKET SHARES OF COMPETITORS www. Marketstocks.com
- 12. STRENGTH OF COMPETITORS •Pharmaceutical companies that operate on Blockbuster business model • Research & Development with the companies rather than outsourcing, Development and production or manufacturing of various drugs/ medicines and healthcare products. •Testing of drugs, marketing and distribution of drugs to appropriate customer segments using various marketing and distribution channels, and managing internal personnel, production, costing, etc
- 14. Thank you